Pulmonary rehabilitation for patients with COPD in rural areas
Decreasing Disparity in Lung Disease: Pulmonary Rehabilitation for Rural Patients With COPD
This study is testing a special rehabilitation program for people with COPD living in rural areas to see if it helps them breathe better and improves their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 306 (estimated) |
| Ages | 40 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 2 sites (Scottsdale, Arizona and 1 other locations) |
| Trial ID | NCT06847061 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the uptake and effectiveness of a pulmonary rehabilitation program specifically designed for patients with Chronic Obstructive Pulmonary Disease (COPD) living in rural areas. It will assess the experiences of patients, caregivers, and healthcare providers involved in the program. The intervention focuses on providing essential rehabilitation services that are often lacking in these regions, with the goal of improving patient outcomes and quality of life.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 40 and older with a physician-diagnosed COPD who reside in rural areas.
Not a fit: Patients who are unable to walk due to orthopedic, neurologic, or cardiac limitations, or those with no significant COPD symptoms, are unlikely to benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance the health and well-being of rural patients suffering from COPD.
How similar studies have performed: Other studies have shown positive outcomes with pulmonary rehabilitation programs, particularly in urban settings, but this approach in rural areas is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria * 40 years of age or older * Physician-diagnosed COPD * Living in a rural area defined by Rural-Urban Commuting Area Codes 4-10 * mMRC score\>=1 * English Speaking Exclusion Criteria * Inability to walk (orthopedic/neurologic/cardiac limitation causing immobility) * Cognitive impairment or inability to understand and follow instructions. * Patients with no COPD symptom burden, no breathlessness (mMRC score 0), as based on our previous studies they usually perceive no benefit from PR and do not have compliance with PR. * Traditional center-based PR was completed within 3 months of initial study recruitment. * Transition to hospice or end-of-life care at the time of screening. * Acute exacerbation at the time of screening.
Where this trial is running
Scottsdale, Arizona and 1 other locations
- Mayo Clinic in Arizona — Scottsdale, Arizona, United States (Recruiting)
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (Recruiting)
Study contacts
- Principal investigator: Roberto Benzo, M.D. — Mayo Clinic
- Study coordinator: Johanna Hoult, M.A.
- Email: Hoult.Johanna@mayo.edu
- Phone: 507-293-1989
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.